Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Mol Cancer Ther. 2012 Aug 21;11(11):2483–2494. doi: 10.1158/1535-7163.MCT-12-0580

Fig. 6.

Fig. 6

Correlation between Cu expression and the treatment outcomes in ovarian cancer patient using different gene probes. (A) hCtr1, (B) hCtr1-unrelated DNA sequence, (C) ATP7A, and (D) ATP7B. In all cases, probes for the given genes are indicated in parentheses, PFS results are shown in the upper panels and the corresponding OS results are shown in the lower panels, high expressers in each panel are shown as red lines and lower expressers are shown in blue, *, p ≤0.05 is considered as significant and is underlined by a red line.